Mixed
Consumption of sugar-sweetened beverages is estimated to be responsible for 8.7% of type 2 diabetes cases in the US and 3.6% in the UK over a 10-year period, assuming causality.
On a population level, reducing sugar-sweetened beverage consumption could prevent a significant number of new diabetes cases in the US and UK. Public health policies targeting SSBs are supported by this evidence.
Under specified assumptions for population attributable fraction... 1.8 million would be attributable to consumption of sugar sweetened beverages (population attributable fraction 8.7%...); and of 2.6 million events in the UK... 79 000 would be attributable to consumption of sugar sweetened beverages (population attributable fraction 3.6%)
Why this rating
Based on robust meta-analysis data applied to national survey data, though dependent on the assumption of causality.
Source
Consumption of sugar sweetened beverages, artificially sweetened beverages, and fruit juice and incidence of type 2 diabetes: systematic review, meta-analysis, and estimation of population attributable fraction
Fumiaki Imamura et al. · BMJ · 2015
DOI 10.1136/bmj.h3576
More from this paper
- Habitual consumption of sugar-sweetened beverages (SSBs) increases the incidence of type 2 diabetes independently of obesity status, with an estimated 13% increased risk per serving per day after adjusting for adiposity.Good
- Artificially sweetened beverages (ASBs) are associated with a 25% increased risk of type 2 diabetes before adjustment for adiposity, which attenuates to 8% after adjustment, but likely involve bias and are not healthy alternatives.Moderate
Related findings · Mixed
- Bariatric surgery (VSG and RYGB) is the most effective and sustainable treatment for obesity, producing marked and sustained weight loss that non-surgical interventions cannot match.Strong
- Severely protein-deficient diets (2–3% energy) induce lean body mass loss and metabolic imbalance, whereas adequate protein intake (0.66 g/kg/d minimum) is a prerequisite for maintaining muscle, bone, and physiological function.Strong
- For patients with Class III obesity (BMI >39.9 kg/m2), metabolic bariatric surgery (MBS) is significantly more effective than any currently approved medication, with BilioPancreatic Diversion (BPD) showing the highest estimated weight loss.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →